AVROBIO, Inc., a leader in lentiviral-based gene therapies,
is a clinical stage company developing disruptive therapies that have the potential
to transform patients’ lives in a single dose.
SIGN UP for our Press Releases
To receive our press releases, please click on the link to sign up. Thank you!